 Kimberly Kelsay
Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotherapy | 1 | 2021 | 149 | 0.660 |
Why?
| | Dermatitis, Atopic | 4 | 2010 | 310 | 0.610 |
Why?
| | Child Psychiatry | 1 | 2017 | 31 | 0.570 |
Why?
| | Cognition | 1 | 2021 | 981 | 0.450 |
Why?
| | Asthma | 4 | 2012 | 2066 | 0.430 |
Why?
| | Pituitary-Adrenal System | 2 | 2012 | 162 | 0.370 |
Why?
| | Life Change Events | 1 | 2012 | 135 | 0.370 |
Why?
| | Hypothalamo-Hypophyseal System | 2 | 2012 | 197 | 0.370 |
Why?
| | Hydrocortisone | 2 | 2012 | 273 | 0.360 |
Why?
| | Leukotriene Antagonists | 1 | 2009 | 41 | 0.340 |
Why?
| | Pediatrics | 1 | 2017 | 986 | 0.340 |
Why?
| | Acetates | 1 | 2009 | 96 | 0.320 |
Why?
| | Quinolines | 1 | 2009 | 129 | 0.310 |
Why?
| | Internship and Residency | 1 | 2017 | 951 | 0.300 |
Why?
| | Sleep Wake Disorders | 2 | 2010 | 233 | 0.280 |
Why?
| | Patient Compliance | 1 | 2010 | 524 | 0.270 |
Why?
| | Depression | 3 | 2021 | 1147 | 0.260 |
Why?
| | Anti-Asthmatic Agents | 1 | 2009 | 350 | 0.260 |
Why?
| | Body Image | 1 | 2005 | 74 | 0.230 |
Why?
| | Stress, Psychological | 1 | 2012 | 975 | 0.230 |
Why?
| | Suicide | 1 | 2009 | 501 | 0.220 |
Why?
| | Personal Satisfaction | 1 | 2005 | 185 | 0.220 |
Why?
| | Primary Health Care | 3 | 2021 | 1518 | 0.190 |
Why?
| | Capacity Building | 1 | 2021 | 51 | 0.180 |
Why?
| | Bias | 1 | 2021 | 179 | 0.170 |
Why?
| | Quality of Life | 1 | 2010 | 2388 | 0.170 |
Why?
| | Food Hypersensitivity | 1 | 2003 | 254 | 0.160 |
Why?
| | Saliva | 2 | 2012 | 189 | 0.140 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 231 | 0.120 |
Why?
| | Humans | 16 | 2021 | 115741 | 0.110 |
Why?
| | Attention | 1 | 2016 | 394 | 0.110 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 362 | 0.100 |
Why?
| | Cognition Disorders | 1 | 2016 | 475 | 0.100 |
Why?
| | Object Attachment | 1 | 2012 | 33 | 0.100 |
Why?
| | Child | 9 | 2021 | 18503 | 0.090 |
Why?
| | Clinical Competence | 1 | 2017 | 912 | 0.090 |
Why?
| | Pruritus | 1 | 2010 | 60 | 0.090 |
Why?
| | Cyclopropanes | 1 | 2009 | 81 | 0.080 |
Why?
| | Parent-Child Relations | 1 | 2012 | 234 | 0.080 |
Why?
| | Risk | 1 | 2012 | 819 | 0.080 |
Why?
| | Interdisciplinary Communication | 1 | 2010 | 185 | 0.080 |
Why?
| | Sulfides | 1 | 2009 | 94 | 0.080 |
Why?
| | Self Report | 1 | 2012 | 699 | 0.080 |
Why?
| | Anti-Allergic Agents | 1 | 2008 | 41 | 0.080 |
Why?
| | Dermatologic Agents | 1 | 2008 | 57 | 0.070 |
Why?
| | Doxepin | 1 | 2006 | 1 | 0.070 |
Why?
| | Social Support | 1 | 2010 | 539 | 0.070 |
Why?
| | Clonidine | 1 | 2006 | 26 | 0.070 |
Why?
| | Histamine H1 Antagonists | 1 | 2006 | 33 | 0.070 |
Why?
| | Suicidal Ideation | 1 | 2010 | 400 | 0.060 |
Why?
| | Anti-Infective Agents | 1 | 2008 | 225 | 0.060 |
Why?
| | Melatonin | 1 | 2006 | 106 | 0.060 |
Why?
| | Adolescent | 5 | 2021 | 17922 | 0.060 |
Why?
| | Hypnotics and Sedatives | 1 | 2006 | 134 | 0.060 |
Why?
| | Mass Screening | 2 | 2021 | 1024 | 0.060 |
Why?
| | Incidence | 1 | 2010 | 2335 | 0.060 |
Why?
| | Anxiety | 1 | 2010 | 854 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 4669 | 0.060 |
Why?
| | Cross Reactions | 1 | 2003 | 117 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2003 | 109 | 0.050 |
Why?
| | Clinical Laboratory Techniques | 1 | 2003 | 87 | 0.050 |
Why?
| | Europe | 1 | 2003 | 336 | 0.050 |
Why?
| | Mental Disorders | 1 | 2009 | 902 | 0.050 |
Why?
| | Parents | 2 | 2008 | 1207 | 0.050 |
Why?
| | Infant | 2 | 2012 | 7979 | 0.050 |
Why?
| | Immune System | 1 | 2003 | 173 | 0.050 |
Why?
| | Prospective Studies | 1 | 2012 | 6276 | 0.050 |
Why?
| | Risk Assessment | 1 | 2009 | 2990 | 0.040 |
Why?
| | Psychology, Child | 1 | 2000 | 37 | 0.040 |
Why?
| | Male | 7 | 2016 | 56050 | 0.040 |
Why?
| | Gender Identity | 1 | 2000 | 103 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2003 | 399 | 0.040 |
Why?
| | Sex Factors | 1 | 2005 | 1739 | 0.040 |
Why?
| | Hypersensitivity | 1 | 2003 | 260 | 0.040 |
Why?
| | Pediatricians | 1 | 2021 | 125 | 0.040 |
Why?
| | Female | 7 | 2016 | 60018 | 0.040 |
Why?
| | Child Behavior Disorders | 1 | 2000 | 128 | 0.040 |
Why?
| | Algorithms | 1 | 2006 | 1500 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2003 | 684 | 0.040 |
Why?
| | Child Behavior | 1 | 2000 | 218 | 0.040 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2006 | 759 | 0.040 |
Why?
| | Risk Factors | 1 | 2010 | 8702 | 0.040 |
Why?
| | Young Adult | 1 | 2012 | 10518 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2269 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 2 | 1990 | 482 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2021 | 805 | 0.030 |
Why?
| | Child, Preschool | 3 | 2016 | 9138 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 1990 | 95 | 0.020 |
Why?
| | Prolactin | 1 | 1990 | 95 | 0.020 |
Why?
| | Severity of Illness Index | 2 | 2008 | 2586 | 0.020 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 1990 | 62 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2008 | 391 | 0.020 |
Why?
| | Genes, Regulator | 1 | 1987 | 33 | 0.020 |
Why?
| | Genes, Fungal | 1 | 1987 | 49 | 0.020 |
Why?
| | Genes | 1 | 1987 | 224 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 1990 | 1122 | 0.020 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2006 | 230 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2006 | 535 | 0.010 |
Why?
| | Cost of Illness | 1 | 2006 | 257 | 0.010 |
Why?
| | Skin Tests | 1 | 2003 | 130 | 0.010 |
Why?
| | Peptides | 1 | 1987 | 864 | 0.010 |
Why?
| | Specimen Handling | 1 | 2003 | 156 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2008 | 2824 | 0.010 |
Why?
| | Projective Techniques | 1 | 2000 | 3 | 0.010 |
Why?
| | Internal-External Control | 1 | 2000 | 67 | 0.010 |
Why?
| | Home Care Services | 1 | 2003 | 226 | 0.010 |
Why?
| | Sex Distribution | 1 | 2000 | 337 | 0.010 |
Why?
| | Aggression | 1 | 2000 | 185 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2000 | 485 | 0.010 |
Why?
| | Recombinant Proteins | 2 | 1990 | 1243 | 0.010 |
Why?
| | Molecular Sequence Data | 2 | 1990 | 2790 | 0.010 |
Why?
| | Amino Acid Sequence | 2 | 1990 | 2000 | 0.010 |
Why?
| | Base Sequence | 2 | 1990 | 2114 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2008 | 9162 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1990 | 77 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 1990 | 63 | 0.010 |
Why?
| | Plasmids | 1 | 1990 | 345 | 0.000 |
Why?
| | Cloning, Molecular | 1 | 1990 | 523 | 0.000 |
Why?
| | Mating Factor | 1 | 1987 | 3 | 0.000 |
Why?
| | Pheromones | 1 | 1987 | 24 | 0.000 |
Why?
| | Crosses, Genetic | 1 | 1987 | 141 | 0.000 |
Why?
| | Protein Conformation | 1 | 1990 | 822 | 0.000 |
Why?
| | Temperature | 1 | 1990 | 587 | 0.000 |
Why?
| | Escherichia coli | 1 | 1990 | 730 | 0.000 |
Why?
| | Genetic Variation | 1 | 1990 | 880 | 0.000 |
Why?
| | Gene Expression | 1 | 1990 | 1436 | 0.000 |
Why?
| | Genotype | 1 | 1987 | 1787 | 0.000 |
Why?
|
|
Kelsay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|